AI assistant
Sending…
Moberg Pharma — Major Shareholding Notification 2016
Dec 7, 2016
3174_iss_2016-12-07_7104267a-3e84-4299-9faf-3a704b2ea7ea.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Moberg Pharma AB (publ)
Holder
Östersjöstiftelsen
Instrument
| Instrument | Ordinary shares SE0003613090 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Share loan | ||
| Date | 07/12/2016 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 658,843 | |
| Directly held voting rights | 658,843 | |
| Indirectly held voting rights | 0 | |
| Percentage | ||
| Directly held shares | 4.61 % | |
| Directly held voting rights | 4.61 % | |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
||
|---|---|---|---|
| Shares | 4.61 % | 658,843 | |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, |
|||
| first paragraph, line 3 | |||
| - Physically settled | |||
| - Cash settled | |||
| Total | 4.61 % | 658,843 | |
| Group total holdings | |||
| Voting rights 658,843 |
|||
| Percentage of voting rights 4.61 | |||
| Notes (other relevant informations according to law) | |||
| Aktielån | |||
| Published |
07/12/2016 17:13
Contact Name Mattias Klintemar Phone 08-6085156 Email [email protected]
*Source of information has chosen not to submit the data
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Moberg Pharma
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 12
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
Apr 24
Regulatory Filings
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 17
AGM Information
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Mar 13